Asymchem Labora.(Tian.)Co.Ltd. Registered Shares H YC 1
- BID
12.7
- ASK
13.2
- 1,088 Units1,041 Units
- 07/24, 13:31:51 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
30.00%
Market Cap
-
P/E Ratio
20.67
Dividend Yield
2.10 %
Earnings per Share
0.39 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 12.7 G | 0 Units |
| PRICE DETERMINATION TIME | 07/24/2026 / 01:31:51 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 12.8 | 12.7 |
| PREV. DAY'S PRICE | 13 | (07/23) |
| CHANGE DAY BEFORE | -0.30 | -2.31 % |
| 52 WEEK HIGH / LOW | 15 (07/15) | 7.7 (12/18) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.82 | 0.35 | 0.39 | 0.49 | 0.65 |
DIVIDENDS PER SHARE | 0.23 | 0.14 | 0.17 | 0.18 | 0.21 |
DIVIDEND YIELD IN % | 2.17 % | 2.34 % | 2.10 % | - | - |
DIVIDEND GROWTH IN % | -3.03 % | -39.02 % | 19.38 % | - | - |
PRICE - EARNINGS RATIO | 13.14 | 17.61 | 20.67 | 26.92 | 20.60 |
PRICE - BOOK RATIO | 1.75 | 1.02 | 1.31 | - | - |
PRICE - SALES RATIO | 3.83 | 2.92 | 3.52 | - | - |
PRICE - CASH FLOW RATIO | 7.96 | 11.85 | 14.63 | - | - |
Master Data
| WKN | A3C8W4 |
| ISIN | CNE100004Z06 |
| SYMBOL | 7K90 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ASYMCHEM LAB.(TIAN.)H YC1 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -11.56 % | 20.37 % | 30.65 % | 44.44 % | 30.00 % | 21.50 % | - | 68.83 % |
| HIGH | 14.30 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | - | 15.00 |
| LOW | 12.80 | 10.40 | 9.40 | 7.70 | 7.70 | 4.32 | - | 7.70 |
Dividende
pro Aktie
Company profile
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.